# Faraday Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/faraday-pharmaceuticals

- Industry: Biotechnology
- Headquarters: Seattle, US
- Website: www.faradaypharma.com
- Latest round: Series A (Jul 8, 2014)
- Investors on record: 5

## About

Established in 2014 and based in Washington, US, Faraday Pharmaceuticals, Inc. operates as a biopharmaceutical company that focuses on research and development of elemental reducing agents (ERAs) that helps to improve patient's outcomes.

## Funding rounds

- Series A, Jul 8, 2014 — ARCH Venture Partners, Polaris Partners, OUP (Osage University Partners), WRF Capital, Alexandria Equities

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series A
- Polaris Partners (https://capitalatlas.ai/funds/polaris-partners) — Series A
- OUP (Osage University Partners) (https://capitalatlas.ai/funds/oup-osage-university-partners) — Series A
- WRF Capital (https://capitalatlas.ai/funds/wrf-capital) — Series A
- Alexandria Equities — Series A